Cocrystal Pharma Inc.

NASDAQ: COCP · Real-Time Price · USD
1.70
0.02 (1.19%)
At close: Aug 15, 2025, 3:45 PM
1.58
-5.95%
Pre-market: Aug 15, 2025, 04:18 AM EDT

Cocrystal Pharma Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
n/a 15.17K 241.6K 239.5K
Gross Profit
n/a -15.17M -241.6K -239.5K
Operating Income
-17.88M -21.16M -38.83M -14.22M
Interest Income
n/a n/a 2.00 4.00
Pretax Income
-17.5M -17.98M -38.84M -14.19M
Net Income
-17.5M -17.98M -38.84M -14.19M
Selling & General & Admin
5.34M 5.99M 5.75M 5.43M
Research & Development
12.54M 15.17M 12.39M 8.79M
Other Expenses
n/a -2.6M 20.69M n/a
Operating Expenses
17.88M 18.56M 17.75M 14.22M
Interest Expense
n/a n/a 2K 4K
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
17.88M 18.56M 18.14M 14.22M
Income Tax Expense
n/a n/a 8K 4K
Shares Outstanding (Basic)
10.17M 9.65M 8.14M 7.69M
Shares Outstanding (Diluted)
10.17M 9.65M 8.14M 7.69M
EPS (Basic)
-1.72 -0.00 -4.77 -1.85
EPS (Diluted)
-1.72 -0.00 -4.77 -1.85
EBITDA
-17.43M -19.37M -17.75M -13.8M
EBIT
-17.88M -17.98M -38.84M -14.18M
Depreciation & Amortization
446K -1.39M 388K 382K